M. Holtkamp

An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients

Marieke A. Vollebergh, Esther H. Lips, Petra M. Nederlof et al. · Annals of Oncology · 2010 · 211 citations · Full text

Medicine, Molecular Genetics, Oncology +15

Feasibility of multiple courses of high-dose cyclophosphamide, thiotepa, and carboplatin for breast cancer or germ cell cancer.

Sjoerd Rodenhuis, Anneke M. Westermann, M. Holtkamp et al. · Journal of Clinical Oncology · 1996 · 93 citations

Medicine, Oncology, Pharmacology +13

Bone marrow reconstitution after high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation: Effect of graft size

Elsken van der Wall, Dick J. Richel, M. Holtkamp et al. · Annals of Oncology · 1994 · 72 citations · Full text

Medicine, Hematology, Oncology +16

Aprepitant inhibits cyclophosphamide bioactivation and thiotepa metabolism

Milly E. de Jonge, Alwin D. R. Huitema, M. Holtkamp et al. · Cancer Chemotherapy and Pharmacology · 2005 · 64 citations

Medicine, Pharmacology, Pharmacotherapy +7

Relationship between exposure and toxicity in high-dose chemotherapy with cyclophosphamide, thiotepa and carboplatin

Alwin D. R. Huitema, Manon C.W. Spaander, Ron A. A. Mathôt et al. · Annals of Oncology · 2002 · 64 citations · Full text

Pharmacy, Oncology, Pharmacology +12